Successful Treatment of a 39-Year-Old COVID-19 Patient with Respiratory Failure by Selective C-Reactive Protein Apheresis

Jan Torzewski; Oliver Zimmermann; Stefan Kayser; Franz Heigl; Florian Wagner; Ahmed Sheriff; Christian Schumann

doi:10.12659/AJCR.932964

05 August 2021 : Case report Germany

Successful Treatment of a 39-Year-Old COVID-19 Patient with Respiratory Failure by Selective C-Reactive Protein Apheresis

Unusual clinical course

Jan Torzewski^1ABCDEF*, Oliver Zimmermann^1BCDEF, Stefan Kayser^2BDF, Franz Heigl^3BDE, Florian Wagner^4BDE, Ahmed Sheriff^25BDEF, Christian Schumann

^6BDEF

DOI: 10.12659/AJCR.932964

Am J Case Rep 2021; 22:e932964

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

View HTML version

Figure 3. (A) CRP apheresis (light red column) and course of CK/CK-MB and LDH plasma levels. Only CK slightly increased, likely due to positioning of the patient (muscular CK). In contrast, CK-MB levels remained normal. (B) CRP apheresis (light red column), bilirubine, international normalized ratio (INR), and creatinine levels. Normal values for each parameter.

Back to the Article

Successful Treatment of a 39-Year-Old COVID-19 Patient with Respiratory Failure by Selective C-Reactive Protein Apheresis

Your Privacy